Do you want to read an article? Please log in or register.
Risk acceleration by gout on major adverse cardiovascular events and all-cause death in patients with diabetes and chronic kidney disease
Cardiovascular Risk and Diseases
Related content
Cardiovascular Risk and Diseases
Bempedoic Acid Reduces the Risk of Major Adverse Cardiovascular Events Across Patient Subgroups
Cardiovascular Risk and Diseases
The association between stress-induced hyperglycemia ratio and cardiovascular events as well as all-cause mortality in patients with chronic kidney disease and diabetic nephropathy
Cardiovasc Diabetol
Cao B, Guo Z, Li DT, Zhao LY, Wang Z, Gao YB, Wang YX
doi: 10.1186/s12933-025-02610-1
Cardiovascular Risk and Diseases
Five-Year Cumulative Cardiovascular Health and Clinical Events in Patients With Chronic Kidney Disease: The CRIC Study
J Am Heart Assoc
Cao Q, Bi Y, Alvarado F, Anderson AH, Mills KT, Jaeger BC, Chen J, He J, Bundy JD, CRIC Study Investigators *
doi: 10.1161/JAHA.123.033001
RECOMMENDED
Cardiovascular Risk and DiseasesFurther Publications
Carotid Plaque Score is Associated with 10-year Major Adverse Cardiovascular Events in Low-Intermediate Risk Patients Referred to a General Cardiology Community Clinic
★ 2
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Eur Heart J Cardiovasc Imaging
Matangi MF, Hétu MF, Armstrong DWJ, Shellenberger J, Brouillard D, Baker J, Johnson A, Grubic N, Willms H, Johri AM
doi: 10.1093/ehjci/jeae153
Heart, Artery and Coronary DiseasesFurther Publications
Angiographic Characteristics and Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing Impella-Supported High-Risk Percutaneous Coronary Intervention: Insights From the cVAD PROTECT III Study
Circ Cardiovasc Interv
Bharadwaj AS, Abu-Much A, Maini AS, Zhou Z, Li Y, Batchelor WB, Grines CL, Baron SJ, Redfors B, Lansky AJ, Basir MB, O'Neill WW
doi: 10.1161/CIRCINTERVENTIONS.123.013503
Cardiovascular Risk and Diseases
Improved prediction and risk stratification of major adverse cardiovascular events using an explainable machine learning approach combining plasma biomarkers and traditional risk factors
Cardiovasc Diabetol
Zhang XR, Zhong WF, Liu RY, Huang JL, Fu JX, Gao J, Zhang PD, Liu D, Li ZH, He Y, Zhou H, Li Z
doi: 10.1186/s12933-025-02711-x
Cardiovascular Risk and Diseases
Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial
Lancet Diabetes Endocrinol
Aggarwal R, Bhatt DL, Szarek M, Cannon CP, Leiter LA, Inzucchi SE, Lopes RD, McGuire DK, Lewis JB, Riddle MC, Davies MJ, Banks P, Carroll AK, Scirica BM, Ray KK, Kosiborod MN, Cherney DZI, Udell JA, Verma S, Mason RP, Pitt B, Steg PG
doi: 10.1016/S2213-8587(24)00362-0
RECOMMENDED
Hypertension
Management of patients with hypertension and chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. On behalf of the European Society of Hypertension Working Group on Hypertension and the Kidney
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Blood Press
Halimi JM, Sarafidis P, Azizi M, Bilo G, Burkard T, Bursztyn M, Camafort M, Chapman N, Cottone S, de Backer T, Deinum J, Delmotte P, Dorobantu M, Doumas M, Dusing R, Duly-Bouhanick B, Fauvel JP, Fesler P, Gaciong Z, Gkaliagkousi E, Gordin D, Grassi G, Grassos C, Guerrot D, Huart J, Izzo R, Jaén Águila F, Járai Z, Kahan T, Kantola I, Kociánová E, Limbourg F, Lopez-Sublet M, Mallamaci F, Manolis A, Marketou M, Mayer G, Mazza A, MacIntyre I, Mourad JJ, Muiesan ML, Nasr E, Nilsson P, Oliveras A, Ormezzano O, Paixão-Dias V, Papadakis I, Papadopoulos D, Perl S, Polónia J, Pontremoli R, Pucci G, Robles NR, Rubin S, Ruilope LM, Rump LC, Saeed S, Sanidas E, Sarzani R, Schmieder R, Silhol F, Sokolovic S, Solbu M, Soucek M, Stergiou G, Sudano I, Tabbalat R, Tengiz I, Triantafyllidi H, Tsioufis K, Václavík J, van der Giet M, der Niepen PV, Veglio F, Venzin R, Viigimaa M, Weber T, Widimsky J, Wuerzner G, Zelveian P, Zebekakis P, Lueders S, Persu A, Kreutz R, Vogt L
doi: 10.1080/08037051.2024.2368800
Hypertension
Major Adverse Cardiovascular Events Following Coronary Artery Stenting by History of Hypertensive Disorder of Pregnancy
J Am Heart Assoc
Gunnarsson OS, Pihlsgård M, Handmark M, Sarno G, Gonçalves I, Timpka S
doi: 10.1161/JAHA.124.035448